IL13 and neoplasm: Furthermore, the hyperactivation of miR-155 by STAT5 contributes to a TH2 phenotype [24], which, through its cytokines (IL-4, IL-5, and IL-13), inhibits the TH1 response [22, 24], preventing an adequate defense of the organism against the tumor.